RXO Inc <RXO.N>: BMO initiates coverage with Outperform rating; price target $35
RXO•Related News
AstraZeneca notifies availability of press release
AZN•
Ryde Group CFO Tee Kok Siong files initial beneficial ownership statement
RYDE•
Not just about oil, remember gas
XLE•
Kura Oncology announces availability of press release on darlifarnib-cabozantinib RCC data update
KURA•
Goldman's profit tops estimates on trading surge, corporate deal spree
GS•